Senators seek to retool drug agency's advertising efforts
- By Louis Jacobson
- November 24, 2003
- Comments
The bill would also end the public-relations and Web-related activities of the White House Office of National Drug Control Policy, and would direct the office to spend 89 percent of its federal appropriation on placing ads.
Shortly before the Hatch-Grassley-Biden bill was introduced, a House-Senate conference committee voted to require that 78 percent of the anti-drug program's $145 million budget be spent on advertising, according to AdAge.com.
Earlier tensions over Ogilvy's contract with the White House office led to an investigation by the General Accounting Office into charges of overbilling by the ad agency. As a result of the investigation, Ogilvy agreed to forgo $1.8 million in federal payments.
However, Ogilvy managed to win a contract renewal, thus irritating the sponsors of the Senate bill and other lawmakers.
Also, the media director for the White House drug-control office, Alan Levitt, quit this fall after feuding with both drug czar John Walters and the Partnership for a Drug-Free America.
By using this service you agree not to post material that is obscene, harassing, defamatory, or otherwise objectionable. Although GovExec.com does not monitor comments posted to this site (and has no obligation to), it reserves the right to delete, edit, or move any material that it deems to be in violation of this rule.
Is Your Privacy Worth 50 Foiled Terror Plots?
Postal Service Eyes Cuba
Tangherlini As GSA's Mr. Fix-It?
Lew Cleans Up Signature for the Nation's Currency
The Plan to Open More Military Jobs to Women
Should Leaders Ever Lie?
Sponsored
Event: Digital Government Success: Meeting the Call for 21st Century Government
What Big Data Means for TSA & Airport Security
Cutting costs: Inside the effort to improve the efficiency of federal operations
